This document provides information about grant funding opportunities through the Colorado Tobacco Education, Prevention and Cessation Grant Program. It outlines several funding initiatives focused on community programs and cessation programs. Details are provided on funding amounts, eligibility requirements, application process, and timelines. Questions from applicants will be answered and posted online by June 8th. The goal is to fund evidence-based programs to reduce tobacco use and increase cessation efforts in Colorado.
Lead Management in SugarCRM Series: Adding LeadsAtcore Systems
The Lead Management in SugarCRM Series outlines everything you need to know about lead management in SugarCRM.
Part 1: Adding Leads
In adding leads we go through the various ways to upload leads into SugarCRM including manual entry, Outlook integration, imports and other methods.
Lead Management in SugarCRM Series: Adding LeadsAtcore Systems
The Lead Management in SugarCRM Series outlines everything you need to know about lead management in SugarCRM.
Part 1: Adding Leads
In adding leads we go through the various ways to upload leads into SugarCRM including manual entry, Outlook integration, imports and other methods.
The Health Improvement Branch, ACT Health provided an update on changes to the ACT Health Promotion Grants Program for the sport and recreation industry on Thursday 6 February 2014. The session detailed the new strategic direction for the program and the aims and objectives of the Healthy Canberra Grants and the Health Promotion Innovation Fund
Developing a Provincial Patient and Family Advisor NetworkCHICommunications
Introductory session on the collaborative planning process that Shared Health’s Public, Patient, and Family Engagement Team led, with patient and family advisors and engagement staff from across the province, to develop a provincial network of advisors.
Join us to learn about the collaborative planning process for the Manitoba Provincial Patient and Family Advisor Network, and how engagement staff can access the Network to help recruit advisors for their projects. We will also share what provincial projects we have been working on and what we see for the future.
Objectives:
• Describe key steps in a collaborative and engaging planning process;
• Discuss current and future engagement initiatives in Manitoba; and
• Use the services of the Patient and Family Advisor Network.
An overview of how to apply for Erasmus+ Youth Key Action 3 funding. For more information, go to our application resources page: https://www.erasmusplus.org.uk/application-resources
The Medicare Advantage Value-Based Insurance Design Model and Part D Payment Modernization Model teams provided a deep dive webinar of the two models on Thursday, February 28 from 3:00 p.m. to 4:00 p.m. EST.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Global grants support large international activities with
sustainable, measurable outcomes in Rotary’s areas of focus.
Hear an overview of global grants and the importance of
Rotarian involvement in monitoring and evaluation. Learn
about scholarships and how you can sponsor or host global
grant scholars. By the end of the session you’ll understand
the components of a quality project and be prepared to start
your global grant application.
Global grants support large international activities with sustainable, measurable outcomes in Rotary’s areas of focus. Hear an overview of global grants and the importance of Rotarian involvement in monitoring and evaluation. Learn about scholarships and how you can sponsor or host global grant scholars. By the end of the session you’ll understand the components of a quality project and be prepared to start your global grant application.
The CMS Innovation Center offered a kickoff webinar event for the Comprehensive End-Stage Renal Disease (ESRD) Care (CEC) Model on Tuesday, May 31, 2016 from 4:00–5 p.m. EDT. This webinar focused on model objectives, terms of the award, eligibility criteria, changes from the first public solicitation and important deadlines. A 20 minute question and answer period followed the presentation.
- - -
CMS Innovation Center
http://innovation.cms.gov
We accept comments in the spirit of our comment policy:
http://newmedia.hhs.gov/standards/comment_policy.html
CMS Privacy Policy
http://cms.gov/About-CMS/Agency-Information/Aboutwebsite/Privacy-Policy.html
Presented by Stephen Cha, MD, MHS of the Centers for Medicare and Medicaid Services at the annual meeting of the Asthma Regional Council of New England, June 13, 2013, Shrewsbury, MA.
Similar to Applicant webinar tobacco cessation initiatives (20)
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
3. During the webinar be sure to have both
RFA guidance documents:
http://www.cdphe.state.co.us/pp/tobacco/grantprogram/ApplyForFunding.html
4. Agenda
• 9am-Noon: Community Initiatives
– Community Tobacco Initiative
– Innovative Community Tobacco Initiative
– Community Led Targeted Outreach Campaigns
• 1pm-4pm: Cessation Initiatives
– QuitLine e-referral System
– Oral Health Partnership
– Pharmacy Partnership
– Hospital Cessation
– Text Message Cessation – Young Adults
– Youth Cessation
5. Agenda cont.
• Funding Period • Application TA
• Purpose • Application Review
• Funding Availability Process
• Eligibility • Post-Award Requirements
• Funding Request Limits • Categories and Questions
• Strategic Goals • Work Plan
• Funding Priority Areas – • Budget
Details and Purpose • Resources
• How to Apply • Other funding initiatives
• Application Timeline • Q&A
6. Funding Period
Year One: Oct. 1, 2012 - June 30, 2013
Year Two: July 1, 2013 - June 30, 2014
Year Three: July 1, 2014 - June 30, 2015
7. RFA Purpose
• Tobacco use is single most preventable cause of
death and disease nationally and in Colorado
• Amendment 35 – voter approved tax increase on
cigarettes and other tobacco products – allocates
funds to tobacco education, prevention, and
cessation programming
• The intent of this RFA is to provide grant funding
to agencies and organizations across the state to
implement evidence-based and innovative
activities to achieve program goals
8. Funding Availability
• ~$19.2 million for the period of Oct 1 through
June 30
• Number and amount of grant awards will vary
• Renewal funding for FY 14 and FY 15 is
contingent upon grantee performance and
appropriation by the Colorado General
Assembly
9. Eligibility
• Not-for-profit organizations
• Public or governmental agencies
• May submit more than one application if
under different funding initiatives
• For-profit – not under this RFA, but can apply
under Health Communications RFPs
10. Funding Request Limits
Cessation Initiatives
• QuitLine e-referral system – as much as $525,000
• Oral Health Partnership – as much as $150,000
• Pharmacy Partnership – as much as $150,000
• Hospital Cessation – as much as $200,000
• Text Message Cessation (Young Adults) – as much
as $250,000
• Youth Cessation – as much as $300,000
11. Break for Questions and Answers
All Questions and Answers will be
posted on June 8
Please submit your questions using the
chat function
12. Strategic Goals
The 2020 goals outlined in this plan guide this Request for Applications are:
• The cessation success gap affecting low SES youth and adult smokers decreases by
50 percent
• A majority of people and health care systems in Colorado recognize and treat
tobacco dependence as a chronic condition
• A majority of Coloradans live, learn, work and play in communities that have
effective policies and regulations that reduce youth and adult use and access to
tobacco
• Tobacco prevalence and initiation among young adults, especially straight-to-work
young adults, decreases by 50 percent
• Initiation among youth, especially high burden and low SES populations, decreases
by 50 percent
• Exposure to secondhand smoke, with an emphasis on low SES populations,
decreases by 50 percent
• Colorado is among 10 states with the highest price for tobacco products
Strategic Plan
13. Funding Priority Areas - Details and Purpose
Cessation Initiatives
– QuitLine e-referral System
• Develop, implement, promote, and evaluate a QuitLine
e-referral system
• Help providers adopt and meaningfully use certified
Electronic Health Record technology
– Oral Health Partnership
• Develop, pilot, and evaluate a program
• Increase QuitLine referrals from oral health providers
• Engage and partner with oral health providers and
clinics to implement strategies to make cessation-
related health systems changes
14. Funding Priority Areas - Details and Purpose
Cessation Initiatives
– Pharmacy Partnership
• Develop, pilot, and evaluate a program
• Increase QuitLine referrals from pharmacists and staff
• Engage and partner with pharmacy providers and
clinics to implement strategies to make cessation-
related health systems changes
– Hospital Cessation
• Develop, pilot, and evaluate a program
• Based on Ottawa Model for Smoking Cessation
15. Funding Priority Areas - Details and Purpose
Cessation Initiatives
– Text Message Cessation (Young Adults)
• Develop, promote, implement, and evaluate a stand-alone
text message based cessation program
• Aimed at young adults with an emphasis on non-students
• Interactive features, deliver evidence-based information
– Youth Cessation
• Develop, promote, implement, and evaluate a youth
cessation program
• Ages 14-18
• Positive youth development framework
• Statewide reach, evidence-based information
16. Break for Questions and Answers
All Questions and Answers will be
posted on June 8
Please submit your questions using the
chat function
17. How to Apply
• Letter of Intent
– Community Tobacco Initiative and
Innovative Community Tobacco Initiative only
• New! Colorado Grants Management System
(COGMS)
– Register by June 15
– Instructions and TA will be provided
• Submit applications electronically by June
29, 5pm
18. Application Timeline
Release of Request for Applications Friday May 18, 2012
Deadline for submission of questions regarding application guidelines via email: Friday June 1, 2012
Applicants’ conference/webinar Tuesday May 29, 2012
Deadline for submission of Letters of Intent for Community Initiatives: Friday June 1, 2012
Responses to all questions received via email and at applicants’ conference will be posted by: Friday June 8, 2012
http://www.cdphe.state.co.us/pp/tobacco/grantprogram/index.html
Compilation of Letters of Intents received illustrating geographic coverage and coordination Friday, June 8, 2012
needs will be posted by:
Responses will be posted here:
http://www.cdphe.state.co.us/pp/tobacco/grantprogram/index.html
Deadline for Registration in Colorado Grants Management System (required for application Friday, June 15, 2012
submission):
Deadline for Application submission: Friday, June 29, 2012 5:00 p.m.
Review of applications June 30 – est. July 20, 2012
Funding recommendations determined by the Tobacco Education, Prevention and Cessation TBD July, 2012
Grant Program Review Committee
Presentation of funding recommendations to the Colorado Board of Health Wednesday Aug. 15, 2012
Funding recommendations will be posted here: Thursday, Aug. 16, 2012
http://www.cdphe.state.co.us/pp/tobacco/grantprogram/index.html
Contract award process Aug. 17 – Sept. 30, 2012
Anticipated award start date Oct. 1, 2012
19. Application TA
• Questions via email through June 1
• FAQ document – posted by June 8
• COGMS Assistance – available throughout
A35COGMSTechnicalAssistance@gmail.com or
303-692-2524
20. Application Review Process
• All applications will be scored on a 100 point
scale
• Minimum of 70 is required to be considered
for funding
• Funding recommendations by Tobacco Review
Committee will be made on July 19 and 20
• Recommendations to the State Board of
Health will be made on August 15
21. Post-Award Requirements
• Certification of non-acceptance of tobacco
industry funds and resources
• Data collection
• Insurance requirements
• Lawful presence
• Lobbying restrictions
• Reimbursement
• Reporting
22. Break for Questions and Answers
All Questions and Answers will be
posted on June 8
Please submit your questions using the
chat function
23. Categories and Questions
• Each initiative has questions listed
• COGMS will state the character limit for each
question and instructions are provided on
how to count characters in the system
• Some questions are required by the Colorado
BOH
24. Work Plan
• A template is not provided, COGMS will walk you
through the steps needed to develop a work plan
• SMART Objectives
• Each objective should address goal(s) outlined in
the strategic plan
• Identify intended outcome
• Describe the intended target population
• Designate a timeline
• Detail the intended measurement tools
• List up to 10 activities
25. Budget
• Must be consistent with proposed work plan
• Provide a budget and justification for initial 9
month funding period only
• Provide separate budgets for each application
• Personnel
– All staff who will work on the project
• Supplies and Operating
– Discouraged and disallowed costs
26. Budget cont.
• Travel
– In state only
– Two, two-day trainings in Denver
• Contractual
– All restrictions apply
– No pre-paid services
• Other
• Indirect
• Financial Assessment Questionnaire
28. Other funding initiatives
Information on the following will be posted on the Tobacco
Collaborative Google Group and final decisions to be made by the
Tobacco Review Committee in July
• Health Communications
– ColoradoQuits: To be posted on the CO BIDS System
– Develop outreach campaign templates: To be posted on the CO BIDS
system
• Technical Assistance and Support
– Will be posted on COGMS by September
• QuitLine
– Sole Source agreement with National Jewish Health
• Evaluation
– Interagency agreement with the Amendment 35 Program Evaluation
Group
29. Question and Answer time…
Please submit your questions
via the chat function
All questions and answers
will be posted on June 8